Opportunity Information: Apply for PAR 25 066
The National Institutes of Health (NIH) is offering a discretionary grant opportunity titled "Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" under Funding Opportunity Number PAR-25-066 (CFDA 93.242). The focus is on late-life suicide risk and how it is shaped by social disconnection, specifically drawing a clear distinction between objective social isolation (for example, limited social contacts or infrequent interaction) and perceived social isolation, commonly described as loneliness. The opportunity is designed to support research projects that can clarify how these forms of disconnection contribute to suicidal thoughts and behaviors in older adults, and how that knowledge can be used to prevent suicide.
A major emphasis of the announcement is on understanding mechanisms. NIH is encouraging studies that identify neurobiological and environmental pathways through which social isolation and loneliness increase suicide risk in late life. This could include work that examines brain, stress, inflammatory, or other biological processes alongside contextual factors such as bereavement, caregiving burdens, reduced mobility, chronic illness, disability, poverty, discrimination, or barriers to accessing supportive services. The goal is not simply to document correlations, but to pinpoint actionable mechanisms that help explain why social disconnection becomes dangerous for some older adults and under what conditions risk escalates.
Another central priority is the use of an experimental therapeutics approach. In practice, that means proposals should be framed around identifying measurable intervention targets, developing or refining interventions that engage those targets, and testing whether changing the target also changes suicide-related outcomes. The "clinical trial optional" designation signals that applicants may propose either clinical trials or non-trial studies, depending on what best fits the question and stage of research. Projects might, for example, test strategies meant to reduce loneliness, increase meaningful social contact, improve perceived belonging, address maladaptive social cognition, or mitigate biological stress responses linked to isolation, while explicitly tracking effects on suicidal ideation, self-harm risk factors, or related clinical endpoints.
The opportunity also highlights service delivery innovation as a key avenue for impact. NIH is looking for research that develops new service models or modifies existing models to strengthen social connection in late life as a suicide prevention strategy. This could involve healthcare systems, community-based aging services, faith-based organizations, public housing settings, telehealth and digital supports, peer or lay navigator programs, or integrated care approaches that connect older adults to social resources. Importantly, the emphasis is on prevention-oriented models that can be implemented in real-world settings, with attention to how programs reach socially disconnected older adults and how services can be adapted to different communities.
This is an R21 mechanism, which generally supports exploratory or developmental research. In that spirit, the funding is geared toward innovative, early-stage, or proof-of-concept projects that can generate strong preliminary evidence, establish feasibility, validate targets or measures, or open up a new line of inquiry. While the posted source data does not specify an award ceiling or the expected number of awards, the intent of the R21 format is typically to enable focused, high-impact studies that can later be scaled or followed by larger, confirmatory research.
Eligibility is broad and includes many types of domestic organizations and governments: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly calls out additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-U.S. entities (foreign organizations). This wide eligibility signals an interest in a diverse range of perspectives and settings, including community and service systems that interact directly with older adults at risk.
Key timeline details provided include a creation date of November 18, 2024, and an original closing date of September 7, 2026. Overall, the opportunity is aimed at advancing practical, mechanism-informed suicide prevention science for older adults by connecting the dots between social isolation, loneliness, biology, environment, and service delivery, and by supporting studies that can translate those insights into targeted interventions and scalable approaches that strengthen social connection in late life.Apply for PAR 25 066
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2024-11-18.
- Applicants must submit their applications by 2026-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: U.S. Embassy Kampala Public Diplomacy Annual Program Statement
Previous opportunity: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 066
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 066) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) Apply for PAR 25 105 Funding Number: PAR 25 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 25 064 Funding Number: PAR 25 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed) Apply for PAR 25 164 Funding Number: PAR 25 164 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) Apply for PAR 24 130 Funding Number: PAR 24 130 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) Apply for PAR 25 166 Funding Number: PAR 25 166 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 26 015 Funding Number: RFA HL 26 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 26 014 Funding Number: RFA HL 26 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) Apply for RFA HG 25 004 Funding Number: RFA HG 25 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Ryan White HIV/AIDS Program Part D - Women, Infants, Children and Youth (WICY) Grant Supplemental Funding Apply for HRSA 25 050 Funding Number: HRSA 25 050 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Data Integration, Systems, and Quality Technical Assistance (DISQ) Apply for HRSA 25 053 Funding Number: HRSA 25 053 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program (RWHAP) Access, Care, and Engagement Technical Assistance Center (ACE TA) Apply for HRSA 25 047 Funding Number: HRSA 25 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Center National Clinician Consultation Center Apply for HRSA 25 061 Funding Number: HRSA 25 061 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance Apply for CDC RFA DD 25 0157 Funding Number: CDC RFA DD 25 0157 Agency: Centers for Disease Control - NCBDDD Category: Health Funding Amount: $290,000 |
| Rural Health Network Development Planning Program Apply for HRSA 25 037 Funding Number: HRSA 25 037 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Rural Veterans Health Access Program Apply for HRSA 25 036 Funding Number: HRSA 25 036 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rural Communities Opioid Response Program-Overdose Response Apply for HRSA 25 010 Funding Number: HRSA 25 010 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Black Lung Data and Resource Center Apply for HRSA 25 039 Funding Number: HRSA 25 039 Agency: Health Resources and Services Administration Category: Health Funding Amount: $135,000 |
| Rural Health Care Services Outreach Program Apply for HRSA 25 038 Funding Number: HRSA 25 038 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Black Lung Clinics Program Apply for HRSA 25 040 Funding Number: HRSA 25 040 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening comprehensive HIV prevention interventions in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA JG 25 0048 Funding Number: CDC RFA JG 25 0048 Agency: Centers for Disease Control-GHC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 066", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
